Chiome Bioscience (4583) Reports Earnings: Revenue Up 8.7% YoY

Chiome Bioscience (4583) has released its financial results, reporting revenue up 8.7% YoY to 273 million yen. On the profit front, the company posted an operating loss of 479 million yen, ordinary loss of 481 million yen, and a net loss of 483 million yen. Basic earnings per share (EPS) stood at -6.62 yen.

From a financial and valuation perspective, the equity ratio is 81.9%, with interest-bearing debt at 70 million yen and retained earnings at -2.0 billion yen. EBITDA was recorded at -980 million yen, with a Return on Equity (ROE) of -65.13% and a Return on Assets (ROA) of -46.84%. As a drug discovery biotech firm, monitoring future research and development milestones, monetization progress, and financial dynamics remains essential.